Actively Recruiting
Efficacy and Safety of Auricular Acupuncture in Depression During the Covid 19 Pandemic
Led by Universidade do Sul de Santa Catarina · Updated on 2025-01-20
280
Participants Needed
1
Research Sites
147 weeks
Total Duration
On this page
Sponsors
U
Universidade do Sul de Santa Catarina
Lead Sponsor
U
University of Sao Paulo
Collaborating Sponsor
AI-Summary
What this Trial Is About
Participants with moderate depressive symptoms measured by PHQ-9 will be randomized to receive auricular acupuncture. The triple blinded procedure will be conducted in 12 sessions (6 weeks). The primary outcome is the response to the treatment 3 months after inclusion.
CONDITIONS
Official Title
Efficacy and Safety of Auricular Acupuncture in Depression During the Covid 19 Pandemic
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 50 years old
- PHQ-9 score between 10 and 19 indicating moderate depression
- Availability to attend treatment sessions
You will not qualify if you...
- Use of complementary and integrative practices in the last 3 months
- Suicidal risk as evaluated by question 9 of the PHQ-9
- Severe depression score on the PHQ-9
- Prior use of auricular acupuncture
- Pregnancy
- Menopause
- Allergy to tape or metal
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Universidade do Sul de Santa Catarina
Palhoça, Santa Catarina, Brazil, 88101000
Actively Recruiting
Research Team
D
Daniel MO Rodrigues, MSc
CONTACT
A
Alexandre F Cury, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here